66X-24504-86973
3 vaccinations
4 coded responses
23 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 947 / CA
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Pfizer-BioNTech
-
2021-03-17
Registered in v-safe
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-03-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-22
- 2021-03-23
- 2021-04-01
- 2021-04-06
-
2021-04-07
Dose 2 — Pfizer-BioNTech
-
2021-04-07
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-14
-
2021-04-21
Survey response — day 14, dose 2MedDRA: Condition aggravated, Pain, Pre-existing disease — Feeling: GoodFree text: Increased fibromyalgia symptoms/flares/body achesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-28
-
2021-05-05
Survey response — day 28, dose 2MedDRA: Fatigue — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Increased fatigue around menstrual periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-12
- 2021-05-19
-
2021-10-06
Survey response — 6 months, dose 2MedDRA: Pain, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Chronic pain spikeMedDRA releases: 2024-11 · check-in free text available
-
2021-11-11
Dose 3 — ModernaCo-administered: Flu
-
2022-05-12
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-05-12
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-13
- 2022-05-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-07 | Pfizer-BioNTech | |
| 3 | 2021-11-11 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-12 | Unsuccessful |
Free text
Release 7 — day 14, dose 2
Symptoms: Increased fibromyalgia symptoms/flares/body aches
Release 8 — day 28, dose 2
Symptoms: Increased fatigue around menstrual period
Release 10 — 6 months, dose 2
Symptoms: Chronic pain spike
Release 11 — 6 months, dose 3
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release